P3BEP (ANZUP 1302): An international randomised phase 3 trial of accelerated versus standard BEP chemotherapy for male and female adults and children with intermediate and poor-risk metastatic germ cell tumours (GCTs) Meeting Abstract


Authors: Zebic, D.; Stockler, M. R.; Martin, A.; Pashankar, F.; Tran, B.; Mazhar, D.; Huddart, R.; Wheater, M.; Walpole, E.; Dunwoodie, E.; Feldman, D.; Birtle, A.; Stevanovic, A. G.; Wyld, D.; Hanning, F. J.; Grimison, P. S.; Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP)
Abstract Title: P3BEP (ANZUP 1302): An international randomised phase 3 trial of accelerated versus standard BEP chemotherapy for male and female adults and children with intermediate and poor-risk metastatic germ cell tumours (GCTs)
Meeting Title: 49th Annual Scientific Meeting of the Clinical Oncology Society of Australia (COSA)
Journal Title: Asia-Pacific Journal of Clinical Oncology
Volume: 18
Issue: Suppl. 3
Meeting Dates: 2022 Nov 2-4
Meeting Location: Brisbane, QLD, Australia
ISSN: 1743-7555
Publisher: Wiley Blackwell  
Date Published: 2022-11-01
Start Page: 235
End Page: 236
Language: English
ACCESSION: WOS:000871956500406
PROVIDER: wos
DOI: 10.1111/ajco.13869
Notes: Meeting Abstract: 455 -- This meeting abstract was published under the "Poster Abstracts" section of the issue -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Darren Richard Feldman
    342 Feldman